Antimicrobial peptide resistance mechanisms of gram-positive bacteria

Antibiotics

Volumn 3, Issue 4, 2014, Pages 461-492

  Nawrocki, Kathryn L ^a   Crispell, Emily K ^a   McBride, Shonna M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AMP; Antimicrobial; Antimicrobial peptide; Clostridium difficile; Resistance

Indexed keywords

ABC TRANSPORTER; ALPHA 2 MACROGLOBULIN; ALPHA DEFENSIN; BACITRACIN; BETA LACTAM; CARDIOLIPIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; DAPTOMYCIN; DERMCIDIN; FIBRIN; GALLIDERMIN; GELATINASE; IMMUNOGLOBULIN; LYSOZYME; MERSACIDIN; METALLOPROTEINASE; N ACETYLGLUCOSAMINE; NISIN; PEPTIDOGLYCAN; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; PLECTASIN; POLYMYXIN B; POLYPEPTIDE ANTIBIOTIC AGENT; POLYSACCHARIDE; PROTEINASE; STAPHYLOKINASE; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACILLUS LICHENIFORMIS; BACILLUS SUBTILIS; BACTERIAL CELL WALL; BACTERIAL MEMBRANE; BACTERIAL SURVIVAL; BINDING AFFINITY; CELL INTERACTION; CLOSTRIDIUM DIFFICILE; ENTEROCOCCUS FAECALIS; ENZYMATIC DEGRADATION; ENZYME INACTIVATION; GRAM POSITIVE BACTERIUM; IMMUNE RESPONSE; LACTOCOCCUS LACTIS; MEMBRANE BIOLOGY; MEMBRANE TRANSPORT; MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN METABOLISM; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PYOGENES;

CLOSTRIDIUM DIFFICILE; POSIBACTERIA;

EID: 85019669882     PISSN: None     EISSN: 20796382     Source Type: Journal    
DOI: 10.3390/antibiotics3040461     Document Type: Review

References (243)

1. Koprivnjak, T.; Peschel, A. Bacterial resistance mechanisms against host defense peptides. Cell. Mol. Life Sci. 2011, 68, 2243-2254.
2. Peschel, A.; Otto, M.; Jack, R.W.; Kalbacher, H.; Jung, G.; Gotz, F. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 1999, 274, 8405-8410.
3. Staubitz, P.; Neumann, H.; Schneider, T.; Wiedemann, I.; Peschel, A. MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance. FEMS Microbiol. Lett. 2004, 231, 67-71.
4. Schmidtchen, A.; Frick, I.M.; Andersson, E.; Tapper, H.; Bjorck, L. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol. Microbiol. 2002, 46, 157-168.
5. Sabat, A.; Kosowska, K.; Poulsen, K.; Kasprowicz, A.; Sekowska, A.; van Den Burg, B.; Travis, J.; Potempa, J. Two allelic forms of the aureolysin gene (aur) within Staphylococcus aureus. Infect. Immun. 2000, 68, 973-976.
6. Lai, Y.; Villaruz, A.E.; Li, M.; Cha, D.J.; Sturdevant, D.E.; Otto, M. The human anionic antimicrobial peptide dermcidin induces proteolytic defence mechanisms in staphylococci. Mol. Microbiol. 2007, 63, 497-506.
7. Hase, C.C.; Finkelstein, R.A. Bacterial extracellular zinc-containing metalloproteases. Microbiol. Rev. 1993, 57, 823-837.
8. Del Papa, M.F.; Hancock, L.E.; Thomas, V.C.; Perego, M. Full activation of Enterococcus faecalis gelatinase by a C-terminal proteolytic cleavage. J. Bacteriol. 2007, 189, 8835-8843.
9. Engelbert, M.; Mylonakis, E.; Ausubel, F.M.; Calderwood, S.B.; Gilmore, M.S. Contribution of gelatinase, serine protease, and fsr to the pathogenesis of Enterococcus faecalis endophthalmitis. Infect. Immun. 2004, 72, 3628-3633.
10. Thurlow, L.R.; Thomas, V.C.; Narayanan, S.; Olson, S.; Fleming, S.D.; Hancock, L.E. Gelatinase contributes to the pathogenesis of endocarditis caused by Enterococcus faecalis. Infect. Immun. 2010, 78, 4936-4943.
11. Sieprawska-Lupa, M.; Mydel, P.; Krawczyk, K.; Wojcik, K.; Puklo, M.; Lupa, B.; Suder, P.; Silberring, J.; Reed, M.; Pohl, J., et al. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob. Agents Chemother. 2004, 48, 4673-4679.
12. Kubica, M.; Guzik, K.; Koziel, J.; Zarebski, M.; Richter, W.; Gajkowska, B.; Golda, A.; Maciag-Gudowska, A.; Brix, K.; Shaw, L. A potential new pathway for Staphylococcus aureus dissemination: The silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS One 2008, 3, e1409.
13. Rivas-Santiago, B.; Hernandez-Pando, R.; Carranza, C.; Juarez, E.; Contreras, J.L.; Aguilar-Leon, D.; Torres, M.; Sada, E. Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells. Infect. Immun. 2008, 76, 935-941.
14. Schittek, B.; Hipfel, R.; Sauer, B.; Bauer, J.; Kalbacher, H.; Stevanovic, S.; Schirle, M.; Schroeder, K.; Blin, N.; Meier, F., et al. Dermcidin: A novel human antibiotic peptide secreted by sweat glands. Nat. Immunol. 2001, 2, 1133-1137.
15. Teufel, P.; Gotz, F. Characterization of an extracellular metalloprotease with elastase activity from Staphylococcus epidermidis. J. Bacteriol. 1993, 175, 4218-4224.
16. Cheung, G.Y.; Rigby, K.; Wang, R.; Queck, S.Y.; Braughton, K.R.; Whitney, A.R.; Teintze, M.; DeLeo, F.R.; Otto, M. Staphylococcus epidermidis strategies to avoid killing by human neutrophils. PLoS Pathog. 2010, 6, e1001133.
17. Hauser, A.R.; Stevens, D.L.; Kaplan, E.L.; Schlievert, P.M. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J. Clin. Microbiol. 1991, 29, 1562-1567.
18. Elliott, S.D. A proteolytic enzyme produced by group A Streptococci with special reference to its effect on the type-specific M antigen. J. Exp. Med. 1945, 81, 573-592.
19. Kapur, V.; Majesky, M.W.; Li, L.L.; Black, R.A.; Musser, J.M. Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc. Natl. Acad. Sci. USA 1993, 90, 7676-7680.
20. Kapur, V.; Topouzis, S.; Majesky, M.W.; Li, L.L.; Hamrick, M.R.; Hamill, R.J.; Patti, J.M.; Musser, J.M. A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb. Pathog. 1993, 15, 327-346.
21. Rasmussen, M.; Bjorck, L. Proteolysis and its regulation at the surface of Streptococcus pyogenes. Mol. Microbiol. 2002, 43, 537-544.
22. Nyberg, P.; Rasmussen, M.; Bjorck, L. Alpha2-Macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37. J. Biol. Chem. 2004, 279, 52820-52823.
23. Rasmussen, M.; Muller, H.P.; Bjorck, L. Protein GRAB of Streptococcus pyogenes regulates proteolysis at the bacterial surface by binding alpha2-macroglobulin. J. Biol. Chem. 1999, 274, 15336-15344.
24. Lauth, X.; von Kockritz-Blickwede, M.; McNamara, C.W.; Myskowski, S.; Zinkernagel, A.S.; Beall, B.; Ghosh, P.; Gallo, R.L.; Nizet, V. M1 protein allows Group. A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition. J. Innate. Immun. 2009, 1, 202-214.
25. Maisey, H.C.; Quach, D.; Hensler, M.E.; Liu, G.Y.; Gallo, R.L.; Nizet, V.; Doran, K.S. A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence. FASEB J. 2008, 22, 1715-1724.
26. Frick, I.M.; Akesson, P.; Rasmussen, M.; Schmidtchen, A.; Bjorck, L. SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J. Biol. Chem. 2003, 278, 16561-16566.
27. Fernie-King, B.A.; Seilly, D.J.; Davies, A.; Lachmann, P.J. Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: Secretory leukocyte proteinase inhibitor and lysozyme. Infect. Immun. 2002, 70, 4908-4916.
28. Jin, T.; Bokarewa, M.; Foster, T.; Mitchell, J.; Higgins, J.; Tarkowski, A. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J. Immunol. 2004, 172, 1169-1176.
29. Braff, M.H.; Jones, A.L.; Skerrett, S.J.; Rubens, C.E. Staphylococcus aureus exploits cathelicidin antimicrobial peptides produced during early pneumonia to promote staphylokinase-dependent fibrinolysis. J. Infect. Dis. 2007, 195, 1365-1372.
30. Diep, D.B.; Havarstein, L.S.; Nes, I.F. Characterization of the locus responsible for the bacteriocin production in Lactobacillus plantarum C11. J. Bacteriol. 1996,178, 4472-4483.
31. Diep, D.B.; Skaugen, M.; Salehian, Z.; Holo, H.; Nes, I.F. Common mechanisms of target cell recognition and immunity for class II bacteriocins. Proc. Natl. Acad. Sci. USA 2007, 104, 2384-2389.
32. Llobet, E.; Tomas, J.M.; Bengoechea, J.A. Capsule polysaccharide is a bacterial decoy for antimicrobial peptides. Microbiology 2008, 154, 3877-3886.
33. Vuong, C.; Kocianova, S.; Voyich, J.M.; Yao, Y.; Fischer, E.R.; DeLeo, F.R.; Otto, M. A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J. Biol. Chem. 2004, 279, 54881-54886.
34. Vuong, C.; Voyich, J.M.; Fischer, E.R.; Braughton, K.R.; Whitney, A.R.; DeLeo, F.R.; Otto, M. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell. Microbiol. 2004, 6, 269-275.
35. Tsuda, H.; Yamashita, Y.; Shibata, Y.; Nakano, Y.; Koga, T. Genes involved in bacitracin resistance in Streptococcus mutans. Antimicrob. Agents Chemother. 2002, 46, 3756-3764.
36. Klein, C.; Entian, K.D. Genes involved in self-protection against the lantibiotic subtilin produced by Bacillus subtilis ATCC 6633. Appl. Environ. Microbiol. 1994, 60, 2793-2801.
37. Kuipers, O.P.; Beerthuyzen, M.M.; Siezen, R.J.; de Vos W.M. Characterization of the nisin gene cluster nisABTCIPR of Lactococcus lactis. Requirement of expression of the nisA and nisI genes for development of immunity. Eur. J. Biochem. 1993, 216, 281-291.
38. Saris, P.E.; Immonen, T.; Reis, M.; Sahl, H.G. Immunity to lantibiotics. Antonie Van Leeuwenhoek 1996, 69, 151-159.
39. Peschel, A.; Vuong, C.; Otto, M.; Gotz, F. The D-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolytic enzymes. Antimicrob. Agents Chemother. 2000, 44, 2845-2847.
40. Abachin, E.; Poyart, C.; Pellegrini, E.; Milohanic, E.; Fiedler, F.; Berche, P.; Trieu-Cuot, P. Formation of D-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol. Microbiol. 2002, 43, 1-14.
41. Abi Khattar, Z.; Rejasse, A.; Destoumieux-Garzon, D.; Escoubas, J.M.; Sanchis, V.; Lereclus, D.; Givaudan, A.; Kallassy, M.; Nielsen-Leroux, C.; Gaudriault, S. The dlt operon of Bacillus cereus is required for resistance to cationic antimicrobial peptides and for virulence in insects. J. Bacteriol. 2009, 191, 7063-7073.
42. Cox, K.H.; Ruiz-Bustos, E.; Courtney, H.S.; Dale, J.B.; Pence, M.A.; Nizet, V.; Aziz, R.K.; Gerling, I.; Price, S.M.; Hasty, D.L. Inactivation of DltA modulates virulence factor expression in Streptococcus pyogenes. PLoS One 2009, 4, e5366.
43. Fisher, N.; Shetron-Rama, L.; Herring-Palmer, A.; Heffernan, B.; Bergman, N.; Hanna, P. The dltABCD operon of Bacillus anthracis sterne is required for virulence and resistance to peptide, enzymatic, and cellular mediators of innate immunity. J. Bacteriol. 2006, 188, 1301-1309.
44. Fittipaldi, N.; Sekizaki, T.; Takamatsu, D.; Harel, J.; Dominguez-Punaro Mde, L.; von Aulock, S.; Draing, C.; Marois, C.; Kobisch, M.; Gottschalk, M. D-Alanylation of lipoteichoic acid contributes to the virulence of Streptococcus suis. Infect. Immun. 2008, 76, 3587-3594.
45. Poyart, C.; Pellegrini, E.; Marceau, M.; Baptista, M.; Jaubert, F.; Lamy, M.C.; Trieu-Cuot, P. Attenuated virulence of Streptococcus agalactiae deficient in D-alanyl-lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells. Mol. Microbiol. 2003, 49, 1615-1625.
46. Maloney, E.; Stankowska, D.; Zhang, J.; Fol, M.; Cheng, Q.J.; Lun, S.; Bishai, W.R.; Rajagopalan, M.; Chatterjee, D.; Madiraju, M.V. The two-domain LysX protein of Mycobacterium tuberculosis is required for production of lysinylated phosphatidylglycerol and resistance to cationic antimicrobial peptides. PLoS Pathog. 2009, 5, e1000534.
47. Samant, S.; Hsu, F.F.; Neyfakh, A.A.; Lee, H. The Bacillus anthracis protein MprF is required for synthesis of lysylphosphatidylglycerols and for resistance to cationic antimicrobial peptides. J. Bacteriol. 2009, 191, 1311-1319.
48. Thedieck, K.; Hain, T.; Mohamed, W.; Tindall, B.J.; Nimtz, M.; Chakraborty, T.; Wehland, J.; Jansch, L. The MprF protein is required for lysinylation of phospholipids in listerial membranes and confers resistance to cationic antimicrobial peptides (CAMPs) on Listeria monocytogenes. Mol. Microbiol. 2006, 62, 1325-1339.
49. Peschel, A.; Jack, R.W.; Otto, M.; Collins, L.V.; Staubitz, P.; Nicholson, G.; Kalbacher, H.; Nieuwenhuizen, W.F.; Jung, G.; Tarkowski, A., et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J. Exp. Med. 2001, 193, 1067-1076.
50. Oku, Y.; Kurokawa, K.; Ichihashi, N.; Sekimizu, K. Characterization of the Staphylococcus aureus mprF gene, involved in lysinylation of phosphatidylglycerol. Microbiology 2004, 150, 45-51.
51. Bera, A.; Herbert, S.; Jakob, A.; Vollmer, W.; Gotz, F. Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol. Microbiol. 2005, 55, 778-787.
52. Bera, A.; Biswas, R.; Herbert, S.; Gotz, F. The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity. Infect. Immun. 2006, 74, 4598-4604.
53. Herbert, S.; Bera, A.; Nerz, C.; Kraus, D.; Peschel, A.; Goerke, C.; Meehl, M.; Cheung, A.; Gotz, F. Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci. PLoS Pathog. 2007, 3, e102.
54. Aubry, C.; Goulard, C.; Nahori, M.A.; Cayet, N.; Decalf, J.; Sachse, M.; Boneca, I.G.; Cossart, P.; Dussurget, O. Oat A, A peptidoglycan O-acetyltransferase involved in Listeria monocytogenes immune escape, is critical for virulence. J. Infect. Dis. 2011, 204, 731-740.
55. Vollmer, W.; Tomasz, A. The pgdA gene encodes for a peptidoglycan N-acetylglucosamine deacetylase in Streptococcus pneumoniae. J. Biol. Chem. 2000, 275, 20496-20501.
56. Fittipaldi, N.; Sekizaki, T.; Takamatsu, D.; Dominguez-Punaro, M.; Harel, J.; Bui, N.K.; Vollmer, W.; Gottschalk, M. Significant contribution of the pgdA gene to the virulence of Streptococcus suis. Mol. Microbiol. 2008, 70, 1120-1135.
57. Boneca, I.G.; Dussurget, O.; Cabanes, D.; Nahori, M.A.; Sousa, S.; Lecuit, M.; Psylinakis, E.; Bouriotis, V.; Hugot, J.P.; Giovannini, M., et al. A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system. Proc. Natl. Acad. Sci. USA 2007, 104, 997-1002.
58. Laaberki, M.H.; Pfeffer, J.; Clarke, A.J.; Dworkin, J. O-Acetylation of peptidoglycan is required for proper cell separation and S-layer anchoring in Bacillus anthracis. J. Biol. Chem. 2011, 286, 5278-5288.
59. Raymond, J.B.; Mahapatra, S.; Crick, D.C.; Pavelka, M.S. Identification of the namH gene, encoding the hydroxylase responsible for the N-glycolylation of the mycobacterial peptidoglycan. J. Biol. Chem. 2005, 280, 326-333.
60. Gajic, O.; Buist, G.; Kojic, M.; Topisirovic, L.; Kuipers, O.P.; Kok, J. Novel mechanism of bacteriocin secretion and immunity carried out by lactococcal multidrug resistance proteins. J. Biol. Chem. 2003, 278, 34291-34298.
61. Kupferwasser, L.I.; Skurray, R.A.; Brown, M.H.; Firth, N.; Yeaman, M.R.; Bayer, A.S. Plasmid-mediated resistance to thrombin-induced platelet microbicidal protein in staphylococci: Role of the qacA locus. Antimicrob. Agents Chemother. 1999, 43, 2395-2399.
62. Mandin, P.; Fsihi, H.; Dussurget, O.; Vergassola, M.; Milohanic, E.; Toledo-Arana, A.; Lasa, I.; Johansson, J.; Cossart, P. VirR, a response regulator critical for Listeria monocytogenes virulence. Mol. Microbiol. 2005, 57, 1367-1380.
63. Collins, B.; Curtis, N.; Cotter, P.D.; Hill, C.; Ross, R.P. The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics. Antimicrob. Agents Chemother. 2010, 54, 4416-4423.
64. Rietkotter, E.; Hoyer, D.; Mascher, T. Bacitracin sensing in Bacillus subtilis. Mol. Microbiol. 2008, 68, 768-785.
65. Schneider, T.; Kruse, T.; Wimmer, R.; Wiedemann, I.; Sass, V.; Pag, U.; Jansen, A.; Nielsen, A.K.; Mygind, P.H.; Raventos, D.S., et al. Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. Science 2010, 328, 1168-1172.
66. Staron, A.; Finkeisen, D.E.; Mascher, T. Peptide antibiotic sensing and detoxification modules of Bacillus subtilis. Antimicrob. Agents Chemother. 2011, 55, 515-525.
67. Mascher, T.; Margulis, N.G.; Wang, T.; Ye, R.W.; Helmann, J.D. Cell wall stress responses in Bacillus subtilis: The regulatory network of the bacitracin stimulon. Mol. Microbiol. 2003, 50, 1591-604.
68. Ohki, R.; Giyanto, A.; Tateno, K.; Masuyama, W.; Moriya, S.; Kobayashi, K.; Ogasawara, N. The BceRS two-component regulatory system induces expression of the bacitracin transporter, BceAB, in Bacillus subtilis. Mol. Microbiol. 2003, 49, 1135-1144.
69. Kawada-Matsuo, M.; Yoshida, Y.; Zendo, T.; Nagao, J.; Oogai, Y.; Nakamura, Y.; Sonomoto, K.; Nakamura, N.; Komatsuzawa, H. Three distinct two-component systems are involved in resistance to the class I bacteriocins, Nukacin ISK-1 and nisin A, in Staphylococcus aureus. PLoS One 2013, 8, e69455.
70. Becker, P.; Hakenbeck, R.; Henrich, B. An ABC transporter of Streptococcus pneumoniae involved in susceptibility to vancoresmycin and bacitracin. Antimicrob. Agents Chemother. 2009, 53, 2034-2041.
71. Majchrzykiewicz, J.A.; Kuipers, O.P.; Bijlsma, J.J. Generic and specific adaptive responses of Streptococcus pneumoniae to challenge with three distinct antimicrobial peptides, bacitracin, LL-37, and nisin. Antimicrob. Agents Chemother. 2010, 54, 440-451.
72. Li, M.; Cha, D.J.; Lai, Y.; Villaruz, A.E.; Sturdevant, D.E.; Otto, M. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol. Microbiol. 2007, 66, 136-147.
73. Sass, P.; Jansen, A.; Szekat, C.; Sass, V.; Sahl, H.G.; Bierbaum, G. The lantibiotic mersacidin is a strong inducer of the cell wall stress response of Staphylococcus aureus. BMC Microbiol. 2008, 8, e186.
74. Yoshida, Y.; Matsuo, M.; Oogai, Y.; Kato, F.; Nakamura, N.; Sugai, M.; Komatsuzawa, H. Bacitracin sensing and resistance in Staphylococcus aureus. FEMS Microbiol. Lett. 2011, 320, 33-39.
75. Hiron, A.; Falord, M.; Valle, J.; Debarbouille, M.; Msadek, T. Bacitracin and nisin resistance in Staphylococcus aureus: a novel pathway involving the BraS/BraR two-component system (SA2417/SA2418) and both the BraD/BraE and VraD/VraE ABC transporters. Mol. Microbiol. 2011, 81, 602-622.
76. Pietiainen, M.; Francois, P.; Hyyrylainen, H.L.; Tangomo, M.; Sass, V.; Sahl, H.G.; Schrenzel, J.; Kontinen, V.P. Transcriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance. BMC Genomics 2009, 10, e429.
77. Meehl, M.; Herbert, S.; Gotz, F.; Cheung, A. Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 2007, 51, 2679-2689.
78. Falord, M.; Karimova, G.; Hiron, A.; Msadek, T. GraXSR proteins interact with the VraFG ABC transporter to form a five-component system required for cationic antimicrobial peptide sensing and resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 2012, 56, 1047-1058.
79. Li, M.; Lai, Y.; Villaruz, A.E.; Cha, D.J.; Sturdevant, D.E.; Otto, M. Gram-positive three-component antimicrobial peptide-sensing system. Proc. Natl. Acad. Sci. USA 2007, 104, 9469-9474.
80. Kramer, N.E.; van Hijum, S.A.; Knol, J.; Kok, J.; Kuipers, O.P. Transcriptome analysis reveals mechanisms by which Lactococcus lactis acquires nisin resistance. Antimicrob. Agents Chemother. 2006, 50, 1753-1761.
81. Podlesek, Z.; Comino, A.; Herzog-Velikonja, B.; Zgur-Bertok, D.; Komel, R.; Grabnar, M. Bacillus licheniformis bacitracin-resistance ABC transporter: Relationship to mammalian multidrug resistance. Mol. Microbiol. 1995, 16, 969-976.
82. Manson, J.M.; Keis, S.; Smith, J.M.; Cook, G.M. Acquired bacitracin resistance in Enterococcus faecalis is mediated by an ABC transporter and a novel regulatory protein, BcrR. Antimicrob. Agents Chemother. 2004, 48, 3743-3748.
83. Matos, R.; Pinto, V.V.; Ruivo, M.; Lopes Mde, F. Study on the dissemination of the bcrABDR cluster in Enterococcus spp. reveals that the BcrAB transporter is sufficient to confer high-level bacitracin resistance. Int. J. Antimicrob. Agents 2009, 34, 142-147.
84. Diaz, M.; Valdivia, E.; Martinez-Bueno, M.; Fernandez, M.; Soler-Gonzalez, A.S.; Ramirez-Rodrigo, H.; Maqueda, M. Characterization of a new operon, as-48EFGH, from the as-48 gene cluster involved in immunity to enterocin AS-48. Appl. Environ. Microbiol. 2003, 69, 1229-1236.
85. McBride, S.M.; Sonenshein, A.L. Identification of a genetic locus responsible for antimicrobial peptide resistance in Clostridium difficile. Infect. Immun. 2011, 79, 167-176.
86. Suarez, J.M.; Edwards, A.N.; McBride, S.M. The Clostridium difficile cpr locus is regulated by a non-contiguous two-component system in response to type A and B lantibiotics. J. Bacteriol. 2013, 195, 2621-2631.
87. Otto, M.; Peschel, A.; Gotz, F. Producer self-protection against the lantibiotic epidermin by the ABC transporter EpiFEG of Staphylococcus epidermidis Tu3298. FEMS Microbiol. Lett. 1998, 166, 203-211.
88. Draper, L.A.; Grainger, K.; Deegan, L.H.; Cotter, P.D.; Hill, C.; Ross, R.P. Cross-immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147. Mol. Microbiol. 2009, 71, 1043-1054.
89. McAuliffe, O.; O’Keeffe, T.; Hill, C.; Ross, R.P. Regulation of immunity to the two-component lantibiotic, lacticin 3147, by the transcriptional repressor LtnR. Mol. Microbiol. 2001, 39, 982-993.
90. Papadelli, M.; Karsioti, A.; Anastasiou, R.; Georgalaki, M.; Tsakalidou, E. Characterization of the gene cluster involved in the biosynthesis of macedocin, the lantibiotic produced by Streptococcus macedonicus. FEMS Microbiol. Lett. 2007, 272, 75-82.
91. Altena, K.; Guder, A.; Cramer, C.; Bierbaum, G. Biosynthesis of the lantibiotic mersacidin: Organization of a type B lantibiotic gene cluster. Appl. Environ. Microbiol. 2000, 66, 2565-2571.
92. Guder, A.; Schmitter, T.; Wiedemann, I.; Sahl, H.G.; Bierbaum, G. Role of the single regulator MrsR1 and the two-component system MrsR2/K2 in the regulation of mersacidin production and immunity. Appl. Environ. Microbiol. 2002, 68, 106-113.
93. Chen, P.; Qi, F.; Novak, J.; Caufield, P.W. The specific genes for lantibiotic mutacin II biosynthesis in Streptococcus mutans T8 are clustered and can be transferred en bloc. Appl. Environ. Microbiol. 1999, 65, 1356-1360.
94. Siegers, K.; Entian, K.D. Genes involved in immunity to the lantibiotic nisin produced by Lactococcus lactis 6F3. Appl. Environ. Microbiol. 1995, 61, 1082-1089.
95. Aso, Y.; Nagao, J.; Koga, H.; Okuda, K.; Kanemasa, Y.; Sashihara, T.; Nakayama, J.; Sonomoto, K. Heterologous expression and functional analysis of the gene cluster for the biosynthesis of and immunity to the lantibiotic, nukacin ISK-1. J. Biosci. Bioeng. 2004, 98, 429-436.
96. Aso, Y.; Sashihara, T.; Nagao, J.; Kanemasa, Y.; Koga, H.; Hashimoto, T.; Higuchi, T.; Adachi, A.; Nomiyama, H.; Ishizaki, A., et al. Characterization of a gene cluster of Staphylococcus warneri ISK-1 encoding the biosynthesis of and immunity to the lantibiotic, nukacin ISK-1. Biosci. Biotechnol. Biochem. 2004, 68, 1663-1671.
97. Hyink, O.; Wescombe, P.A.; Upton, M.; Ragland, N.; Burton, J.P.; Tagg, J.R. Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12. Appl. Environ. Microbiol. 2007, 73, 1107-1113.
98. McLaughlin, R.E.; Ferretti, J.J.; Hynes, W.L. Nucleotide sequence of the streptococcin A-FF22 lantibiotic regulon: model for production of the lantibiotic SA-FF22 by strains of Streptococcus pyogenes. FEMS Microbiol. Lett. 1999, 175, 171-177.
99. Biswas, S.; Biswas, I. SmbFT, a putative ABC transporter complex, confers protection against the lantibiotic Smb in Streptococci. J. Bacteriol. 2013, 195, 5592-5601.
100. Stein, T.; Heinzmann, S.; Dusterhus, S.; Borchert, S.; Entian, K.D. Expression and functional analysis of the subtilin immunity genes spaIFEG in the subtilin-sensitive host Bacillus subtilis MO1099. J. Bacteriol. 2005, 187, 822-828.
101. Rabijns, A.; de Bondt, H.L.; de Ranter, C. Three-dimensional structure of staphylokinase, a plasminogen activator with therapeutic potential. Nat. Struct. Biol. 1997, 4, 357-360.
102. Akesson, P.; Sjoholm, A.G.; Bjorck, L. Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function. J. Biol. Chem. 1996, 271, 1081-1088.
103. Pence, M.A.; Rooijakkers, S.H.; Cogen, A.L.; Cole, J.N.; Hollands, A.; Gallo, R.L.; Nizet, V. Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 group A Streptococcus. J. Innate Immun. 2010, 2, 587-595.
104. Buckley, A.M.; Spencer, J.; Candlish, D.; Irvine, J.J.; Douce, G.R. Infection of hamsters with the UK Clostridium difficile ribotype 027 outbreak strain R20291. J. Med. Microbiol. 2011, 60, 1174-1180.
105. Xia, G.; Wolz, C. Phages of Staphylococcus aureus and their impact on host evolution. Infect. Genet. Evol. 2014, 21, 593-601.
106. Van Wamel, W.J.; Rooijakkers, S.H.; Ruyken, M.; van Kessel, K.P.; van Strijp, J.A. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. J. Bacteriol. 2006, 188, 1310-1315.
107. Coleman, D.C.; Sullivan, D.J.; Russell, R.J.; Arbuthnott, J.P.; Carey, B.F.; Pomeroy, H.M. Staphylococcus aureus bacteriophages mediating the simultaneous lysogenic conversion of beta-lysin, staphylokinase and enterotoxin A: Molecular mechanism of triple conversion. J. Gen. Microbiol. 1989, 135, 1679-1697.
108. Jin, T.; Bokarewa, M.; McIntyre, L.; Tarkowski, A.; Corey, G.R.; Reller, L.B.; Fowler, V.G. Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains. J. Med. Microbiol. 2003, 52, 919-923.
109. Bisno, A.L.; Brito, M.O.; Collins, C.M. Molecular basis of group A streptococcal virulence. Lancet Infect. Dis. 2003, 3, 191-200.
110. Madzivhandila, M.; Adrian, P.V.; Cutland, C.L.; Kuwanda, L.; Madhi, S.A. Distribution of pilus islands of group B streptococcus associated with maternal colonization and invasive disease in South Africa. J. Med. Microbiol. 2013, 62, 249-253.
111. Maisey, H.C.; Hensler, M.; Nizet, V.; Doran, K.S. Group B streptococcal pilus proteins contribute to adherence to and invasion of brain microvascular endothelial cells. J. Bacteriol. 2007, 189, 1464-1467.
112. Chatterjee, C.; Paul, M.; Xie, L.; van der Donk W.A. Biosynthesis and mode of action of lantibiotics. Chem. Rev. 2005, 105, 633-684.
113. Alkhatib, Z.; Abts, A.; Mavaro, A.; Schmitt, L.; Smits, S.H. Lantibiotics: How do producers become self-protected? J. Biotechnol. 2012, 159, 145-154.
114. Halami, P.M.; Stein, T.; Chandrashekar, A.; Entian, K.D. Maturation and processing of SpaI, the lipoprotein involved in subtilin immunity in Bacillus subtilis ATCC 6633. Microbiol. Res. 2010, 165, 183-189.
115. Hoffmann, A.; Schneider, T.; Pag, U.; Sahl, H.G. Localization and functional analysis of PepI, the immunity peptide of Pep5-producing Staphylococcus epidermidis strain 5. Appl. Environ. Microbiol. 2004, 70, 3263-3271.
116. Christ, N.A.; Bochmann, S.; Gottstein, D.; Duchardt-Ferner, E.; Hellmich, U.A.; Dusterhus, S.; Kotter, P.; Guntert, P.; Entian, K.D.; Wohnert, J. The First structure of a lantibiotic immunity protein, SpaI from Bacillus subtilis, reveals a novel fold. J. Biol. Chem. 2012, 287, 35286-35298.
117. Qiao, M.; Immonen, T.; Koponen, O.; Saris, P.E. The cellular location and effect on nisin immunity of the NisI protein from Lactococcus lactis N8 expressed in Escherichia coli and L. lactis. FEMS Microbiol. Lett. 1995, 131, 75-80.
118. Takala, T.M.; Saris, P.E. C terminus of NisI provides specificity to nisin. Microbiology 2006, 152, 3543-3549.
119. Reis, M.; Eschbach-Bludau, M.; Iglesias-Wind, M.I.; Kupke, T.; Sahl, H.G. Producer immunity towards the lantibiotic Pep5: Identification of the immunity gene pepI and localization and functional analysis of its gene product. Appl. Environ. Microbiol. 1994, 60, 2876-2883.
120. Skaugen, M.; Abildgaard, C.I.; Nes, I.F. Organization and expression of a gene cluster involved in the biosynthesis of the lantibiotic lactocin S. Mol. Gen. Genet. 1997, 253, 674-686.
121. Heidrich, C.; Pag, U.; Josten, M.; Metzger, J.; Jack, R.W.; Bierbaum, G.; Jung, G.; Sahl, H.G. Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster. Appl. Environ. Microbiol. 1998, 64, 3140-3146.
122. Twomey, D.; Ross, R.P.; Ryan, M.; Meaney, B.; Hill, C. Lantibiotics produced by lactic acid bacteria: structure, function and applications. Antonie Van Leeuwenhoek 2002, 82, 165-185.
123. Peterson, P.K.; Wilkinson, B.J.; Kim, Y.; Schmeling, D.; Quie, P.G. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect. Immun. 1978, 19, 943-949.
124. Nelson, A.L.; Roche, A.M.; Gould, J.M.; Chim, K.; Ratner, A.J.; Weiser, J.N. Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance. Infect. Immun. 2007, 75, 83-90.
125. Ashbaugh, C.D.; Warren, H.B.; Carey, V.J.; Wessels, M.R. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J. Clin. Invest. 1998, 102, 550-560.
126. Kogan, G.; Uhrin, D.; Brisson, J.R.; Paoletti, L.C.; Blodgett, A.E.; Kasper, D.L.; Jennings, H.J. Structural and immunochemical characterization of the type VIII group B Streptococcus capsular polysaccharide. J. Biol. Chem. 1996, 271, 8786-8790.
127. Bentley, S.D.; Aanensen, D.M.; Mavroidi, A.; Saunders, D.; Rabbinowitsch, E.; Collins, M.; Donohoe, K.; Harris, D.; Murphy, L.; Quail, M.A., et al. Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet. 2006, 2, e31.
128. Candela, T.; Fouet, A. Bacillus anthracis CapD, belonging to the gamma-glutamyltranspeptidase family, is required for the covalent anchoring of capsule to peptidoglycan. Mol. Microbiol. 2005, 57, 717-726.
129. Deng, L.; Kasper, D.L.; Krick, T.P.; Wessels, M.R. Characterization of the linkage between the type III capsular polysaccharide and the bacterial cell wall of group B Streptococcus. J. Biol. Chem. 2000, 275, 7497-7504.
130. Mack, D.; Fischer, W.; Krokotsch, A.; Leopold, K.; Hartmann, R.; Egge, H.; Laufs, R. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: Purification and structural analysis. J. Bacteriol. 1996, 178, 175-183.
131. Campos, M.A.; Vargas, M.A.; Regueiro, V.; Llompart, C.M.; Alberti, S.; Bengoechea, J.A. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect. Immun. 2004, 72, 7107-7114.
132. Rupp, M.E.; Fey, P.D.; Heilmann, C.; Gotz, F. Characterization of the importance of Staphylococcus epidermidis autolysin and polysaccharide intercellular adhesin in the pathogenesis of intravascular catheter-associated infection in a rat model. J. Infect. Dis. 2001, 183, 1038-1042.
133. Rupp, M.E.; Ulphani, J.S.; Fey, P.D.; Bartscht, K.; Mack, D. Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model. Infect. Immun. 1999, 67, 2627-2632.
134. Beiter, K.; Wartha, F.; Hurwitz, R.; Normark, S.; Zychlinsky, A.; Henriques-Normark, B. The capsule sensitizes Streptococcus pneumoniae to alpha-defensins human neutrophil proteins 1 to 3. Infect. Immun. 2008, 76, 3710-3716.
135. Wartha, F.; Beiter, K.; Albiger, B.; Fernebro, J.; Zychlinsky, A.; Normark, S.; Henriques-Normark, B. Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps. Cell. Microbiol. 2007, 9, 1162-1171.
136. Jansen, A.; Szekat, C.; Schroder, W.; Wolz, C.; Goerke, C.; Lee, J.C.; Turck, M.; Bierbaum, G. Production of capsular polysaccharide does not influence Staphylococcus aureus vancomycin susceptibility. BMC Microbiol. 2013, 13, e65.
137. Boman, H.G. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 1995, 13, 61-92.
138. Powers, J.P.; Hancock, R.E. The relationship between peptide structure and antibacterial activity. Peptides 2003, 24, 1681-1691.
139. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415, 389-395.
140. Nizet, V. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr. Issues. Mol. Biol. 2006, 8, 11-26.
141. Peschel, A. How do bacteria resist human antimicrobial peptides? Trends Microbiol. 2002, 10, 179-186.
142. Hancock, R.E.; Rozek, A. Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol. Lett. 2002, 206, 143-149.
143. Weidenmaier, C.; Peschel, A. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat. Rev. Microbiol. 2008, 6, 276-287.
144. Goldfine, H. Bacterial membranes and lipid packing theory. J. Lipid. Res. 1984, 25, 1501-1507.
145. Wiese, A.; Munstermann, M.; Gutsmann, T.; Lindner, B.; Kawahara, K.; Zahringer, U.; Seydel, U. Molecular mechanisms of polymyxin B-membrane interactions: Direct correlation between surface charge density and self-promoted transport. J. Membr. Biol. 1998, 162, 127-138.
146. Ernst, C.M.; Peschel, A. Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids. Mol. Microbiol. 2011, 80, 290-299.
147. Ernst, C.M.; Staubitz, P.; Mishra, N.N.; Yang, S.J.; Hornig, G.; Kalbacher, H.; Bayer, A.S.; Kraus, D.; Peschel, A. The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion. PLoS Pathog. 2009, 5, e1000660.
148. Kristian, S.A.; Durr, M.; van Strijp, J.A.; Neumeister, B.; Peschel, A. MprF-mediated lysinylation of phospholipids in Staphylococcus aureus leads to protection against oxygen-independent neutrophil killing. Infect. Immun. 2003, 71, 546-549.
149. Bao, Y.; Sakinc, T.; Laverde, D.; Wobser, D.; Benachour, A.; Theilacker, C.; Hartke, A.; Huebner, J. Role of mprF1 and mprF2 in the pathogenicity of Enterococcus faecalis. PLoS One 2012, 7, e38458.
150. Hachmann, A.B.; Angert, E.R.; Helmann, J.D. Genetic analysis of factors affecting susceptibility of Bacillus subtilis to daptomycin. Antimicrob. Agents Chemother. 2009, 53, 1598-1609.
151. Maloney, E.; Lun, S.; Stankowska, D.; Guo, H.; Rajagoapalan, M.; Bishai, W.R.; Madiraju, M.V. Alterations in phospholipid catabolism in Mycobacterium tuberculosis lysX mutant. Front. Microbiol. 2011, 2, e19.
152. Weidenmaier, C.; Peschel, A.; Kempf, V.A.; Lucindo, N.; Yeaman, M.R.; Bayer, A.S. DltABCD-and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model. Infect. Immun. 2005, 73, 80338038.
153. Mukhopadhyay, K.; Whitmire, W.; Xiong, Y.Q.; Molden, J.; Jones, T.; Peschel, A.; Staubitz, P.; Adler-Moore, J.; McNamara, P.J.; Proctor, R.A., et al. In vitro susceptibility of Staphylococcus aureus to thrombin-induced platelet microbicidal protein-1 (tPMP-1) is influenced by cell membrane phospholipid composition and asymmetry. Microbiology 2007, 153, 1187-1197.
154. Ruzin, A.; Severin, A.; Moghazeh, S.L.; Etienne, J.; Bradford, P.A.; Projan, S.J.; Shlaes, D.M. Inactivation of mprF affects vancomycin susceptibility in Staphylococcus aureus. Biochim. Biophys. Acta 2003, 1621, 117-121.
155. Nishi, H.; Komatsuzawa, H.; Fujiwara, T.; McCallum, N.; Sugai, M. Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus. Antimicrob. Agents Chemother. 2004, 48, 4800-4807.
156. Jones, T.; Yeaman, M.R.; Sakoulas, G.; Yang, S.J.; Proctor, R.A.; Sahl, H.G.; Schrenzel, J.; Xiong, Y.Q.; Bayer, A.S. Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. Antimicrob. Agents Chemother. 2008, 52, 269-278.
157. Friedman, L.; Alder, J.D.; Silverman, J.A. Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrob. Agents Chemother. 2006, 50, 2137-2145.
158. Yang, S.J.; Mishra, N.N.; Rubio, A.; Bayer, A.S. Causal role of single nucleotide polymorphisms within the mprF gene of Staphylococcus aureus in daptomycin resistance. Antimicrob. Agents Chemother. 2013, 57, 5658-5664.
159. Salzberg, L.I.; Helmann, J.D. Phenotypic and transcriptomic characterization of Bacillus subtilis mutants with grossly altered membrane composition. J. Bacteriol. 2008, 190, 7797-7807.
160. Roy, H.; Ibba, M. Broad range amino acid specificity of RNA-dependent lipid remodeling by multiple peptide resistance factors. J. Biol. Chem. 2009, 284, 29677-29683.
161. Mishra, N.N.; Yang, S.J.; Chen, L.; Muller, C.; Saleh-Mghir, A.; Kuhn, S.; Peschel, A.; Yeaman, M.R.; Nast, C.C.; Kreiswirth, B.N., et al. Emergence of daptomycin resistance in daptomycin-naive rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms. PLoS One 2013, 8, e71151.
162. Slavetinsky, C.J.; Peschel, A.; Ernst, C.M. Alanyl-phosphatidylglycerol and lysyl-phosphatidylglycerol are translocated by the same MprF flippases and have similar capacities to protect against the antibiotic daptomycin in Staphylococcus aureus. Antimicrob. Agents Chemother. 2012, 56, 3492-3497.
163. McBride, S.M.; Sonenshein, A.L. The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile. Microbiology 2011, 157, 1457-1465.
164. Walter, J.; Loach, D.M.; Alqumber, M.; Rockel, C.; Hermann, C.; Pfitzenmaier, M.; Tannock, G.W. D-alanyl ester depletion of teichoic acids in Lactobacillus reuteri 100-23 results in impaired colonization of the mouse gastrointestinal tract. Environ. Microbiol. 2007, 9, 1750-1760.
165. Koprivnjak, T.; Mlakar, V.; Swanson, L.; Fournier, B.; Peschel, A.; Weiss, J.P. Cation-induced transcriptional regulation of the dlt operon of Staphylococcus aureus. J. Bacteriol. 2006, 188, 3622-3630.
166. Le Jeune, A.; Torelli, R.; Sanguinetti, M.; Giard, J.C.; Hartke, A.; Auffray, Y.; Benachour, A. The extracytoplasmic function sigma factor SigV plays a key role in the original model of lysozyme resistance and virulence of Enterococcus faecalis. PLoS One 2010, 5, e9658.
167. Neuhaus, F.C.; Heaton, M.P.; Debabov, D.V.; Zhang, Q. The dlt operon in the biosynthesis of D-alanyl-lipoteichoic acid in Lactobacillus casei. Microb. Drug Resist. 1996, 2, 77-84.
168. Perego, M.; Glaser, P.; Minutello, A.; Strauch, M.A.; Leopold, K.; Fischer, W. Incorporation of D-alanine into lipoteichoic acid and wall teichoic acid in Bacillus subtilis. Identification of genes and regulation. J. Biol. Chem. 1995, 270, 15598-15606.
169. Neuhaus, F.C.; Baddiley, J. A continuum of anionic charge: Structures and functions of D-alanyl-teichoic acids in gram-positive bacteria. Microbiol. Mol. Biol. Rev. 2003, 67, 686-723.
170. Yang, S.J.; Kreiswirth, B.N.; Sakoulas, G.; Yeaman, M.R.; Xiong, Y.Q.; Sawa, A.; Bayer, A.S. Enhanced expression of dltABCD is associated with the development of daptomycin nonsusceptibility in a clinical endocarditis isolate of Staphylococcus aureus. J. Infect. Dis. 2009, 200, 1916-1920.
171. Guariglia-Oropeza, V.; Helmann, J.D. Bacillus subtilis sigma(V) confers lysozyme resistance by activation of two cell wall modification pathways, peptidoglycan O-acetylation and D-alanylation of teichoic acids. J. Bacteriol. 2011, 193, 6223-6232.
172. Jann, N.J.; Schmaler, M.; Kristian, S.A.; Radek, K.A.; Gallo, R.L.; Nizet, V.; Peschelm, A.; Landmann, R. Neutrophil antimicrobial defense against Staphylococcus aureus is mediated by phagolysosomal but not extracellular trap-associated cathelicidin. J. Leukoc. Biol. 2009, 86, 1159-1169.
173. Saar-Dover, R.; Bitler, A.; Nezer, R.; Shmuel-Galia, L.; Firon, A.; Shimoni, E.; Trieu-Cuot, P.; Shai, Y. D-Alanylation of lipoteichoic acids confers resistance to cationic peptides in group B streptococcus by increasing the cell wall density. PLoS Pathog. 2012, 8, e1002891.
174. Kristian, S.A.; Lauth, X.; Nizet, V.; Goetz, F.; Neumeister, B.; Peschel, A.; Landmann, R. Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model. J. Infect. Dis. 2003, 188, 414-423.
175. Collins, L.V.; Kristian, S.A.; Weidenmaier, C.; Faigle, M.; van Kessel, K.P.; van Strijp, J.A.; Gotz, F.; Neumeister, B.; Peschel, A. Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. J. Infect. Dis. 2002, 186, 214-219.
176. Meyer, K.; Thompson, R.; Palmer, J.W.; Khorazo, D. The nature of lysozyme action. Science 1934, 79, 61.
177. Meyer, K.; Palmer, J.W.; Thompson, R.; Khorazo, D. On the mechanism of lysozyme action. J. Biol. Chem. 1936, 113, 479-486.
178. Chipman, D.M.; Sharon, N. Mechanism of lysozyme action. Science 1969, 165, 454-465.
179. Nash, J.A.; Ballard, T.N.; Weaver, T.E.; Akinbi, H.T. The peptidoglycan-degrading property of lysozyme is not required for bactericidal activity in vivo. J. Immunol. 2006, 177, 519-526.
180. Hebert, L.; Courtin, P.; Torelli, R.; Sanguinetti, M.; Chapot-Chartier, M.P.; Auffray, Y.; Benachour, A. Enterococcus faecalis constitutes an unusual bacterial model in lysozyme resistance. Infect. Immun. 2007, 75, 5390-5398.
181. Amano, K.; Araki, Y.; Ito, E. Effect of N-acyl substitution at glucosamine residues on lysozyme-catalyzed hydrolysis of cell-wall peptidoglycan and its oligosaccharides. Eur. J. Biochem. 1980, 107, 547-553.
182. Amano, K.; Hayashi, H.; Araki, Y.; Ito, E. The action of lysozyme on peptidoglycan with N-unsubstituted glucosamine residues. Isolation of glycan fragments and their susceptibility to lysozyme. Eur. J. Biochem. 1977, 76, 299-307.
183. Psylinakis, E.; Boneca, I.G.; Mavromatis, K.; Deli, A.; Hayhurst, E.; Foster, S.J.; Varum, K.M.; Bouriotis, V. Peptidoglycan N-acetylglucosamine deacetylases from Bacillus cereus, highly conserved proteins in Bacillus anthracis. J. Biol. Chem. 2005, 280, 30856-30863.
184. Blair, D.E.; Schuttelkopf, A.W.; MacRae, J.I.; van Aalten D.M. Structure and metal-dependent mechanism of peptidoglycan deacetylase, a streptococcal virulence factor. Proc. Natl. Acad. Sci. USA 2005, 102, 15429-15434.
185. Vollmer, W.; Tomasz, A. Peptidoglycan N-acetylglucosamine deacetylase, a putative virulence factor in Streptococcus pneumoniae. Infect. Immun. 2002, 70, 7176-7178.
186. Benachour, A.; Ladjouzi, R.; le Jeune, A.; Hebert, L.; Thorpe, S.; Courtin, P.; Chapot-Chartier, M.P.; Prajsnar, T.K.; Foster, S.J.; Mesnage, S. The lysozyme-induced peptidoglycan N-acetylglucosamine deacetylase PgdA (EF1843) is required for Enterococcus faecalis virulence. J. Bacteriol. 2012, 194, 6066-6073.
187. Rae, C.S.; Geissler, A.; Adamson, P.C.; Portnoy, D.A. Mutations of the Listeria monocytogenes peptidoglycan N-deacetylase and O-acetylase result in enhanced lysozyme sensitivity, bacteriolysis, and hyperinduction of innate immune pathways. Infect. Immun. 2011, 79, 3596-3606.
188. Crisostomo, M.I.; Vollmer, W.; Kharat, A.S.; Inhulsen, S.; Gehre, F.; Buckenmaier, S.; Tomasz, A. Attenuation of penicillin resistance in a peptidoglycan O-acetyl transferase mutant of Streptococcus pneumoniae. Mol. Microbiol. 2006, 61, 1497-1509.
189. Bera, A.; Biswas, R.; Herbert, S.; Kulauzovic, E.; Weidenmaier, C.; Peschel, A.; Gotz, F. Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus. J. Bacteriol. 2007, 189, 280-283.
190. Davis, K.M.; Akinbi, H.T.; Standish, A.J.; Weiser, J.N. Resistance to mucosal lysozyme compensates for the fitness deficit of peptidoglycan modifications by Streptococcus pneumoniae. PLoS Pathog. 2008, 4, e1000241.
191. Veiga, P.; Bulbarela-Sampieri, C.; Furlan, S.; Maisons, A.; Chapot-Chartier, M.P.; Erkelenz, M.; Mervelet, P.; Noirot, P.; Frees, D.; Kuipers, O.P., et al. SpxB regulates O-acetylation-dependent resistance of Lactococcus lactis peptidoglycan to hydrolysis. J. Biol. Chem. 2007, 282, 19342-19354.
192. Shimada, T.; Park, B.G.; Wolf, A.J.; Brikos, C.; Goodridge, H.S.; Becker, C.A.; Reyes, C.N.; Miao, E.A.; Aderem, A.; Gotz, F., et al. Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion. Cell Host Microbe 2010, 7, 38-49.
193. Brennan, P.J.; Nikaido, H. The envelope of mycobacteria. Annu. Rev. Biochem. 1995, 64, 29-63.
194. Mazzotta, A.S.; Montville, T.J. Nisin induces changes in membrane fatty acid composition of Listeria monocytogenes nisin-resistant strains at 10 degrees C and 30 degrees C. J. Appl. Microbiol. 1997, 82, 32-38.
195. Verheul, A.; Russell, N.J.; van’t Hof, R.; Rombouts, F.M.; Abee, T. Modifications of membrane phospholipid composition in nisin-resistant Listeria monocytogenes Scott A. Appl. Environ. Microbiol. 1997, 63, 3451-3457.
196. Ming, X.T.; Daeschel, M.A. Nisin resistance of foodborne bacteria and the specific resistance responses of Listeria monocytogenes Scott A. J. Food Protect. 1993, 56, 944-948
197. Crandall, A.D.; Montville, T.J. Nisin resistance in Listeria monocytogenes ATCC 700302 is a complex phenotype. Appl. Environ. Microbiol. 1998, 64, 231-237.
198. Mishra, N.N.; McKinnell, J.; Yeaman, M.R.; Rubio, A.; Nast, C.C.; Chen, L.; Kreiswirth, B.N.; Bayer, A.S. In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates. Antimicrob. Agents Chemother. 2011, 55, 4012-4018.
199. Mishra, N.N.; Liu, G.Y.; Yeaman, M.R.; Nast, C.C.; Proctor, R.A.; McKinnell, J.; Bayer, A.S. Carotenoid-related alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides. Antimicrob. Agents Chemother. 2011, 55, 526-531.
200. Mishra, N.N.; Rubio, A.; Nast, C.C.; Bayer, A.S. Differential adaptations of methicillin-resistant Staphylococcus aureus to serial in vitro passage in daptomycin: Evolution of daptomycin resistance and role of membrane carotenoid content and fluidity. Int. J. Microbiol. 2012, 2012, e683450.
201. Britton, G. Structure and properties of carotenoids in relation to function. FASEB J. 1995, 9, 1551-1558.
202. Pelz, A.; Wieland, K.P.; Putzbach, K.; Hentschel, P.; Albert, K.; Gotz, F. Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus. J. Biol. Chem. 2005, 280, 32493-32498.
203. Katzif, S.; Lee, E.H.; Law, A.B.; Tzeng, Y.L.; Shafer, W.M. CspA regulates pigment production in Staphylococcus aureus through a SigB-dependent mechanism. J. Bacteriol. 2005, 187, 8181-8184.
204. Subczynski, W.K.; Wisniewska, A. Physical properties of lipid bilayer membranes: Relevance to membrane biological functions. Acta Biochim. Pol. 2000, 47, 613-625.
205. Wisniewska, A.; Subczynski, W.K. Effects of polar carotenoids on the shape of the hydrophobic barrier of phospholipid bilayers. Biochim. Biophys. Acta 1998, 1368, 235-246.
206. Bayer, A.S.; Prasad, R.; Chandra, J.; Koul, A.; Smriti, M.; Varma, A.; Skurray, R.A.; Firth, N.; Brown, M.H.; Koo, S.P., et al. In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity. Infect. Immun. 2000, 68, 3548-3553.
207. Van Blitterswijk, W.J.; van der Meer, B.W.; Hilkmann, H. Quantitative contributions of cholesterol and the individual classes of phospholipids and their degree of fatty acyl (un)saturation to membrane fluidity measured by fluorescence polarization. Biochemistry 1987, 26, 1746-1756.
208. Davidson, A.L.; Chen, J. ATP-binding cassette transporters in bacteria. Annu. Rev. Biochem. 2004, 73, 241-268.
209. Davidson, A.L.; Dassa, E.; Orelle, C.; Chen, J. Structure, function, and evolution of bacterial ATP-binding cassette systems. Microbiol. Mol. Biol. Rev. 2008, 72, 317-364.
210. Pao, S.S.; Paulsen, I.T.; Saierk, M.H. Major facilitator superfamily. Microbiol. Mol. Biol. Rev. 1998, 62, 1-34.
211. Reizer, J.; Reizer, A.; Saier, M.H. A new subfamily of bacterial ABC-type transport systems catalyzing export of drugs and carbohydrates. Protein Sci. 1992, 1, 1326-1332.
212. Stein, T.; Heinzmann, S.; Kiesau, P.; Himmel, B.; Entian, K.D. The spa-box for transcriptional activation of subtilin biosynthesis and immunity in Bacillus subtilis. Mol. Microbiol. 2003, 47, 1627-1636.
213. Stein, T.; Heinzmann, S.; Solovieva, I.; Entian, K.D. Function of Lactococcus lactis nisin immunity genes nisI and nisFEG after coordinated expression in the surrogate host Bacillus subtilis. J. Biol. Chem. 2003, 278, 89-94.
214. Immonen, T.; Saris, P.E. Characterization of the nisFEG operon of the nisin Z producing Lactococcus lactis subsp. lactis N8 strain. DNA Seq. 1998, 9, 263-274.
215. Ra, S.R.; Qiao, M.; Immonen, T.; Pujana, I.; Saris, E.J. Genes responsible for nisin synthesis, regulation and immunity form a regulon of two operons and are induced by nisin in Lactoccocus lactis N8. Microbiology 1996, 142, 1281-1288.
216. Aso, Y.; Okuda, K.; Nagao, J.; Kanemasa, Y.; Thi Bich Phuong, N.; Koga, H.; Shioya, K.; Sashihara, T.; Nakayama, J.; Sonomoto, K. A novel type of immunity protein, NukH, for the lantibiotic nukacin ISK-1 produced by Staphylococcus warneri ISK-1. Biosci. Biotechnol. Biochem. 2005, 69, 1403-1410.
217. Okuda, K.; Yanagihara, S.; Shioya, K.; Harada, Y.; Nagao, J.; Aso, Y.; Zendo, T.; Nakayama, J.; Sonomoto, K. Binding specificity of the lantibiotic-binding immunity protein NukH. Appl. Environ. Microbiol. 2008, 74, 7613-7619.
218. Gebhard, S. ABC transporters of antimicrobial peptides in Firmicutes bacteria-Phylogeny, function and regulation. Mol. Microbiol. 2012, 86, 1295-1317.
219. Higgins, C.F. ABC transporters: Physiology, structure and mechanism-An overview. Res. Microbiol. 2001, 152, 205-210.
220. Dintner, S.; Staron, A.; Berchtold, E.; Petri, T.; Mascher, T.; Gebhard, S. Coevolution of ABC transporters and two-component regulatory systems as resistance modules against antimicrobial peptides in Firmicutes bacteria. J. Bacteriol. 2011, 193, 3851-3862.
221. Revilla-Guarinos, A.; Gebhard, S.; Mascher, T.; Zuniga, M. Defence against antimicrobial peptides: Different strategies in Firmicutes. Environ. Microbiol. 2014, 16, 1225-1237.
222. Bernard, R.; El Ghachi, M.; Mengin-Lecreulx, D.; Chippaux, M.; Denizot, F. BcrC from Bacillus subtilis acts as an undecaprenyl pyrophosphate phosphatase in bacitracin resistance. J. Biol. Chem. 2005, 280, 28852-28857.
223. Shaaly, A.; Kalamorz, F.; Gebhard, S.; Cook, G.M. Undecaprenyl pyrophosphate phosphatase confers low-level resistance to bacitracin in Enterococcus faecalis. J. Antimicrob. Chemother. 2013, 68, 1583-1593.
224. Charlebois, A.; Jalbert, L.A.; Harel, J.; Masson, L.; Archambault, M. Characterization of genes encoding for acquired bacitracin resistance in Clostridium perfringens. PLoS One 2012, 7, e44449.
225. Butaye, P.; Cloeckaert, A.; Schwarz, S. Mobile genes coding for efflux-mediated antimicrobial resistance in Gram-positive and Gram-negative bacteria. Int. J. Antimicrob. Agents 2003, 22, 205-210.
226. Van Veen, H.W.; Venema, K.; Bolhuis, H.; Oussenko, I.; Kok, J.; Poolman, B.; Driessen, A.J.; Konings, W.N. Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1. Proc. Natl. Acad. Sci. USA 1996, 93, 10668-10672.
227. Saidijam, M.; Benedetti, G.; Ren, Q.; Xu, Z.; Hoyle, C.J.; Palmer, S.L.; Ward, A.; Bettaney, K.E.; Szakonyi, G.; Meuller, J., et al. Microbial drug efflux proteins of the major facilitator superfamily. Curr. Drug Targets 2006, 7, 793-811.
228. Littlejohn, T.G.; Paulsen, I.T.; Gillespie, M.T.; Tennent, J.M.; Midgley, M.; Jones, I.G.; Purewal, A.S.; Skurray, R.A. Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus. FEMS Microbiol. Lett. 1992, 74, 259-265.
229. Leelaporn, A.; Paulsen, I.T.; Tennent, J.M.; Littlejohn, T.G.; Skurray, R.A. Multidrug resistance to antiseptics and disinfectants in coagulase-negative staphylococci. J. Med. Microbiol. 1994, 40, 214-220.
230. Bayer, A.S.; Cheng, D.; Yeaman, M.R.; Corey, G.R.; McClelland, R.S.; Harrel, L.J.; Fowler, V.G. In vitro resistance to thrombin-induced platelet microbicidal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source. Antimicrob. Agents Chemother. 1998, 42, 3169-3172.
231. Solheim, M.; Aakra, A.; Vebo, H.; Snipen, L.; Nes, I.F. Transcriptional responses of Enterococcus faecalis V583 to bovine bile and sodium dodecyl sulfate. Appl. Environ. Microbiol. 2007, 73, 5767-5774.
232. Fernandez-Fuentes, M.A.; Abriouel, H.; Ortega Morente, E.; Perez Pulido, R.; Galvez, A. Genetic determinants of antimicrobial resistance in Gram positive bacteria from organic foods. Int. J. Food Microbiol. 2014, 172, 49-56.
233. Gay, K.; Stephens, D.S. Structure and dissemination of a chromosomal insertion element encoding macrolide efflux in Streptococcus pneumoniae. J. Infect. Dis. 2001, 184, 56-65.
234. Peschel, A.; Sahl, H.G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 2006, 4, 529-536.
235. Eckert, R. Road to clinical efficacy: Challenges and novel strategies for antimicrobial peptide development. Future Microbiol. 2011, 6, 635-651.
236. Marr, A.K.; Gooderham, W.J.; Hancock, R.E. Antibacterial peptides for therapeutic use: Obstacles and realistic outlook. Curr. Opin. Pharmacol. 2006, 6, 468-472.
237. Hancock, R.E.; Sahl, H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 2006, 24, 1551-1557.
238. Van Heel, A.J.; Mu, D.; Montalban-Lopez, M.; Hendriks, D.; Kuipers, O.P. Designing and producing modified, new-to-nature peptides with antimicrobial activity by use of a combination of various lantibiotic modification enzymes. ACS Synth. Biol. 2013, 2, 397-404.
239. Jung, W.J.; Mabood, F.; Souleimanov, A.; Zhou, X.; Jaoua, S.; Kamoun, F.; Smith, D.L. Stability and antibacterial activity of bacteriocins produced by Bacillus thuringiensis and Bacillus thuringiensis ssp. kurstaki. J. Microbiol. Biotechnol. 2008, 18, 1836-1840.
240. Chehimi, S.; Delalande, F.; Sable, S.; Hajlaoui, M.R.; van Dorsselaer, A.; Limam, F.; Pons, A.M. Purification and partial amino acid sequence of thuricin S, a new anti-Listeria bacteriocin from Bacillus thuringiensis. Can. J. Microbiol. 2007, 53, 284-290.
241. Weigel, L.M.; Clewell, D.B.; Gill, S.R.; Clark, N.C.; McDougal, L.K.; Flannagan, S.E.; Kolonay, J.F.; Shetty, J.; Killgore, G.E.; Tenover, F.C. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 2003, 302, 1569-1571.
242. Huddleston, J.R. Horizontal gene transfer in the human gastrointestinal tract: Potential spread of antibiotic resistance genes. Infect. Drug. Resist. 2014, 7, 167-176.
243. Napier, B.A.; Band, V.; Burd, E.M.; Weiss, D.S. Colistin heteroresistance in Enterobacter cloacae is associated with cross-resistance to the host antimicrobial lysozyme. Antimicrob. Agents Chemother. 2014, 58, 5594-5597.